Dr Francine Heatley is a Trial Manager at the UKCRC registered Imperial Clinical Trials Unit (ICTU) in the School of Public Health within the Faculty of Medicine at Imperial College.
Francine is a Biology graduate from the University of Nottingham and has over 15 years experience of conducting clinical research in therapeutic areas such as vascular surgery, cardiovascular and oncology . She spend 3 years working for an academic research organisation in Canada and is familiar in both Health Canada and FDA clinical trial regulations.
At Imperial, she currently manages the JP Moulton funded DAVE (Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration) Trial and previously manged the NIHR EVRA (Early Venous Reflux Ablation) ulcer trial: A randomised clinical trial to compare early versus delayed endovenous treatment of superficial venous reflux in patients with chronic venous ulceration. The study results were published in the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/nejmoa1801214
Francine completed her PhD in Leg Ulcer outcomes at Imperial College London in June 2021.
et al., 2021, Study protocol for a multicentre, randomised controlled trial to compare the use of the decellularised dermis allograft in addition to standard care versus standard care alone for the treatment of venous leg ulceration: DAVE trial, Bmj Open, Vol:11, ISSN:2044-6055
et al., 2021, The management of venous leg ulceration post the EVRA (early venous reflux ablation) ulcer trial: Management of venous ulceration post EVRA, Phlebology, Vol:36, ISSN:0268-3555, Pages:203-208
et al., 2020, Primary care survey of venous leg ulceration management and referral pre-EVRA trial., Br J Community Nurs, Vol:25, ISSN:1462-4753, Pages:S6-S10
Heatley F, Onida S, Davies AH, 2020, The global management of leg ulceration: Pre early venous reflux ablation trial, Phlebology, Vol:35, ISSN:0268-3555, Pages:576-582
et al., 2020, Long-term clinical and cost-effectiveness of early endovenous ablation in venous ulceration (The EVRA randomized clinical trial), Jama: Journal of the American Medical Association, ISSN:0098-7484